Abstract 2584
Background
Approximately 20-30% of non-melanoma skin cancers are squamous cell carcinomas of the skin (SCCS). SCCS incidence is increasing and they often occur in elderly or immunosuppressed patients (pts). SCCS can progress to stages impossible to treat by surgical excision or radiotherapy. Cisplatin-based combinations show efficacy but are too toxic for elderly pts. Cetuximab (Ce) demonstrates 69% disease control rate (DCR) at 6 weeks but in few, highly selected pts. This study aims to evaluate the efficacy of Ce in non-selected pts with SCCS.
Methods
This retrospective study included pts with relapsing unresectable or metastatic SCCS treated with Ce monotherapy (weekly loading dose 400 and 250 mg/m²). The primary objective was DCR at 6 weeks. 60 pts (38 male) with local relapses of metastatic CSCC (100%), were treated between 30/05/2007 and 07/04/2017 in 13 centers. Median age was 83.1 yrs (min 47.4, max 96.1 yrs). Two-thirds of pts had one or two comorbidities, including 13% (n = 8) with immune disorder. 54% had local relapse. Main metastatic locations were nodes (n = 15), lung (n = 8) and skin (n = 5). 90% were chemotherapy-naïve, 57% had previous radiotherapy, and all were primarily resected. Mean time between previous treatment and Ce was 20.1 months (min 0, max 300). Mean Ce injection number was 24.8 (min 4, max 60).
Results
Complete response, partial response, stabilization (S) and progression were 7%, 48%, 32% and 13%, respectively, at 6 weeks and 2%, 42%, 29% and 27% at 3 months. 90% of pts experienced at least a disease S as best overall response. Ce was discontinued in 1 patient after first injection due to grade III infusion-related toxicity. All other grade III toxicities were cutaneous (n = 8) with 5 discontinuations. No toxic deaths were reported. Median follow-up, progression-free survival and overall survival were 11.7 months [95% CI: 9.6-30.1], 9.7 months [95% CI: 4.8-43.4] and 17.5 months [95% CI: 9.4-43.1] respectively.
Conclusions
Cetuximab is a safe and efficient treatment for patients, even very old, with SCCS. The toxicity profile of Ce compares very favorably with cisplatine-based protocols. These results indicate that Ce is a promising platform to test new combinations.
Clinical trial identification
Legal entity responsible for the study
Centre Antoine Lacassagne.
Funding
Merck KGaA.
Editorial Acknowledgement
Disclosure
F. Peyrade: Board member: Merck KGaA. All other authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract